Welcome to clonexpress.com
.
.
Technology:
Patient-Specific cells: Beta Cells, Dopaminergic neuron, Hepatocytes
Clonexpress has developed a patented technology to develop patient-specific
differentiated cell types from human primary fibroblasts and peripheral blood
mononuclear cells (PBMNC) by epigenetic induction.
Cost effective development of patient-specific pancreatic beta cells, hepatocytes,
neuronal cells from PBMNC provided by investigators. Fast turnaround time (usually
about 4-6 weeks). Send enquiries.
Technology
Cell Lines available for evaluation and licencing:
Additional cell lines are under different stages of development.
Patient-Specific cells: Beta Cells, Dopaminergic neuron, Hepatocytes
Clonexpress has developed a patented technology to develop patient-specific
differentiated cell types from human primary fibroblasts and peripheral blood
mononuclear cells (PBMNC) by epigenetic induction.
Cost effective development of patient-specific pancreatic beta cells, hepatocytes,
neuronal cells from PBMNC provided by investigators. Fast turnaround time (usually
about 4-6 weeks). Send enquiries.
Technology
Cell Lines available for evaluation and licencing:
 | Human fetal and adult pancreatic beta cell | |
| Human dopaminergic neuron | |
| Human neuronal progenitor cell | |
| Human astrocytes |
Additional cell lines are under different stages of development.
Clonexpress also provides human CNS primary cells and other primary cell
types for in vitro research.
types for in vitro research.
| Astrocytes HAST | |
| Dopaminergic neuron cells DAN Cells | |
| Microglial cells HMG | |
| Neuronal progenitor cells HNPC | |
| Hepatocytes - Special Introductory offer | |
| Pancreatic beta cells - Special Introductory offer | |
| Reprogremmed Alzheimer's microglial cells and neurons |
CLONEXPRESS
Innovations in Cell Based Therapy and Drug Discovery
Innovations in Cell Based Therapy and Drug Discovery
 | |  | |  | |  |